Project Title: |
mRNA-lipid nanoparticles (mRNA-LNP) for treating cystinosis |
Project Type: |
Translational research |
Disease group(s): |
Metabolic & stone disorders |
Project Summary: |
mRNA-LNP are a new technology to deliver RNA for therapeutic purposes. We aim to test CTNS mRNA-LNPs for treating cystinosis, a lysosomal storage disease due to the CTNS gene mutations. In this translational project we investigate the potential of CTNS mRNA-LNP to correct cystinosis phenotype in cell and animal models of cystinosis. |
Lead principal investigator(s): |
Elena Levtchenko, Amsterdam Bert van den Heuvel, Nijmegen |
Project Period: |
10/2020 - 10/2024 |
Sponsors: |
National funding agency |